Top Markets
Coin of the day
Solasia Pharma K.K. Solasia Pharma K.K.

Solasia Pharma K.K.

4597
Κατάταξη σε μετοχές #24765
Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is... Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is dedicated to the development and commercialization of oncology treatments throughout Japan and other parts of Asia. The company's marketed products include SP-03 (episil oral liquid), designed for the protection and relief of oral pain and inflammation (mucositis/stomatitis) resulting from cancer chemotherapy and radiation. Additionally, they offer SP-01 (Sancuso), a transdermal patch that delivers granisetron, an anti-emetic, into the bloodstream to manage chemotherapy-induced nausea and vomiting. Solasia Pharma's development pipeline features SP-02 (Darinaparsin), a mitochondrial-targeted agent that has successfully completed Phase III clinical trials for a range of hematologic and solid cancers. Also in Phase III clinical study is SP-05 (Arfolitixorin), which aims to bolster the anti-tumor effectiveness of fluorouracil in various cancers, including pancreatic, breast, stomach, and head and neck cancers. In its pre-clinical stage, SP-04 is being developed to address chemotherapy-induced peripheral neuropathy.
Τιμή μετοχής
$0.20877985
Κεφαλαιοποίηση
$57.00M
Αλλαγή (1 ημέρα)
-11.11%
Αλλαγή (1 έτος)
-20.59%
Χώρα
JP
Εμπόριο Solasia Pharma K.K. (4597)

Κατηγορία

Ιστορικό τιμής μετοχής για την Solasia Pharma K.K. (4597)
Υψηλότερη τιμή κλεισίματος: $0.21 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $2.17 στις 2017-03-01
Ιστορικό τιμής μετοχής της Solasia Pharma K.K. από 2017 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 1.92%
2025 -28.32%
2024 -29.74%
2023 6.85%
2022 -59.89%
2021 -29.23%
2020 -20.28%
2019 12.42%
2018 -61.95%
2017 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$171.67 -
DE
$163.63 27.51%
DE
$37.61 23.06%
JP
$223.11 32.17%
CH
$20.99 11.74%
IN